Naturally occurring NF-kappaB inhibitors.

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Pharmacology

Background:

• Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) regulates critical cell signaling pathways involved in inflammation.
• Dysregulation of NF-kappaB is implicated in various inflammatory and autoimmune diseases, making it a significant therapeutic target.
• Numerous pro-inflammatory mediators, including cytokines, chemokines, and enzymes, are under the control of NF-kappaB.

Purpose of the Study:

• To review the medicinal chemistry of plant-derived compounds that inhibit the NF-kappaB pathway.
• To highlight the potential of natural substances as therapeutic agents for inflammatory conditions.
• To provide an overview of different classes of phytochemicals targeting NF-kappaB.

Main Methods:

• Literature review of scientific publications on NF-kappaB inhibitors and plant-derived compounds.
• Analysis of the chemical structures and inhibitory mechanisms of various natural products.
• Categorization of compounds based on their chemical class (e.g., lignans, sesquiterpenes, polyphenols).

Main Results:

• A diverse array of plant-derived compounds, including lignans, sesquiterpenes, diterpenes, triterpenes, and polyphenols, have demonstrated NF-kappaB inhibitory activity.
• Specific examples of active compounds such as parthenolide, resveratrol, and quercetin are discussed.
• The medicinal chemistry of these natural inhibitors offers insights into their structure-activity relationships.

Conclusions:

• Plant-derived compounds represent a promising source of novel therapeutic agents for managing inflammatory diseases by targeting the NF-kappaB pathway.
• Further research into the medicinal chemistry of these natural products could lead to the development of new anti-inflammatory drugs.
• Selective inhibition of NF-kappaB by natural compounds holds potential for treating conditions like arthritis, asthma, and autoimmune disorders.